Neurelis to Present New Pediatric Data on VALTOCO®...
Category : Product Related Updates 9 October 2025Neurelis, Inc., the neuroscience company behind VALTOCO® (diazepam nasal spray), announced it wi...
Neurelis, Inc., the neuroscience company behind VALTOCO® (diazepam nasal spray), announced it wi...
The U.S. Food and Drug Administration (FDA) has extended the target action date for Sanofi’s t...
Ascletis Pharma Inc. (HKEX: 1672) announced positive topline data from the ASC47-103 trial, showing...
London, UK — AMO Pharma Limited, a clinical-stage specialty biopharmaceutical company focused...
ALS (amyotrophic lateral sclerosis) is one of the most devastating diagnoses anyone can receive. A d...